Genetronics starts trials of cancer drug delivery:
This article was originally published in Clinica
Trials of Genetronics' electric field-based drug delivery system have begun at nine US centres to test the effectiveness of the technique on difficult-to-treat head and neck cancers. The company, from San Diego California has developed the electroporation therapy that creates temporary pores in cells using electric fields into which drugs can enter. The Phase II trial will follow 25 patients and further sites will join the study. Patients in France and Canada are also being treated for head and neck cancers.